Phenotypic diversity in delayed drug hypersensitivity: an immunologic explanation

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Background:

• Drug hypersensitivity reactions are a significant cause of iatrogenic illness.
• Historically classified as type IV hypersensitivity, T-cells are now recognized as directing the inflammatory cascade in delayed drug allergy.

Observation:

• Delayed drug hypersensitivity involves drug-specific CD4+ and CD8+ T cells recognizing drugs via T-cell receptors and MHC.
• Drug interaction with T-cell receptors occurs through peptide binding or direct structural interaction.
• Phenotypic patterns of delayed drug hypersensitivity correlate with specific cytokine profiles.

Findings:

• Maculopapular exanthema can be TH-1 or TH-2 driven (Interferon-gamma/TNF-alpha or Interleukin-4, 5, 13).
• Bullous reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) involve CD8+ T-cells and Fas/perforin/granzyme B cytotoxicity.
• Pustular exanthema is mediated by T-cell release of IL-8 and granulocyte-monocyte colony-stimulating factor (GM-CSF).

Implications:

• Delayed type IV hypersensitivity reactions are reclassified into four subtypes: IVa (TH-1), IVb (TH-2), IVc (CD8+), and IVd (IL-8/GM-CSF).
• Understanding these inflammatory cascades aids in diagnosing and managing drug hypersensitivity.
• Clinical manifestations often represent an overlap of cytokine pathways, with one dominant reaction pattern.